Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (301-310 of 918) with videos related to

Pageof 92
Sort By:
BJU International|July 2, 2016
Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalitiesSami-Ramzi Leyh-Bannurah, Hiba Abou-Haidar, Paolo Dell'Oglio, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
The Journal of Urology|February 8, 2002
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomyMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
European Urology|April 22, 2006
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital chargesAlvaro Ramirez, Serge Benayoun, Alberto Briganti, et al.
BJU International|May 30, 2013
Sociodemographic disparities in the treatment of small renal massesAndreas Becker, Florian Roghmann, Quoc-Dien Trinh, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
World Journal of Urology|November 1, 2016
Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancerKatharina Boehm, Paolo Dell'Oglio, Zhe Tian, et al.
Pageof 92

Showing results (301-310 of 918) with videos related to

Sort By:
Pageof 92
BJU International|July 2, 2016
Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalitiesSami-Ramzi Leyh-Bannurah, Hiba Abou-Haidar, Paolo Dell'Oglio, et al.
European Urology|January 14, 2014
A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomyBurkhard Beyer, Thorsten Schlomm, Pierre Tennstedt, et al.
The Journal of Urology|February 8, 2002
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomyMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
European Urology|April 22, 2006
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital chargesAlvaro Ramirez, Serge Benayoun, Alberto Briganti, et al.
BJU International|May 30, 2013
Sociodemographic disparities in the treatment of small renal massesAndreas Becker, Florian Roghmann, Quoc-Dien Trinh, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
World Journal of Urology|November 1, 2016
Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancerKatharina Boehm, Paolo Dell'Oglio, Zhe Tian, et al.
Pageof 92